stenosis and multisite or recurrent CVOD. Complex/hybrid interventions were performed in 72 patients possessing 79 complex lesions (26% of all cases); 29 required bifurcation carotid endarterectomy (CEA) and concomitant treatment of long-length or tandem common carotid artery (CCA) lesions, 16 needed internal carotid artery resection/shortening for long-length disease and excessive tortuosity, 8 required concomitant posterior territory revascularization (subclavian bypass or vertebral transposition), 16 were treated for recurrent carotid stenosis, and 10 had prior neck dissection/irradiation for carcinoma (the last two groups were treated with autologous vein patch or interposition graft). Concomitant CCA lesions were treated by distal CCA transection and proximal eversion endarterectomy (>3 cm length) in 19 cases, retrograde proximal CCA or innominate stenting in 7, and polytetrafluoroethylene bypass replacement in 3 patients. The 30-day adverse events and late reconstruction patency were compared with 3 concurrent patient control groups including 185 standard CEAs for isolated bifurcation disease, 21 transfemoral carotid artery stenting procedures for high-risk indications, and 31 primary stenting procedures of arch origin stenoses (CCA or innominate). Simultaneous CEA with open cardiac surgery and cross CCA-CCA bypass cases were excluded; 85% of patients had follow-up imaging beyond 30 to 60 days with an annual surveillance duplex ultrasound (mean duration of 2.7 years; range to 9 years).
stenosis and multisite or recurrent CVOD. Complex/hybrid interventions were performed in 72 patients possessing 79 complex lesions (26% of all cases); 29 required bifurcation carotid endarterectomy (CEA) and concomitant treatment of long-length or tandem common carotid artery (CCA) lesions, 16 needed internal carotid artery resection/shortening for long-length disease and excessive tortuosity, 8 required concomitant posterior territory revascularization (subclavian bypass or vertebral transposition), 16 were treated for recurrent carotid stenosis, and 10 had prior neck dissection/irradiation for carcinoma (the last two groups were treated with autologous vein patch or interposition graft). Concomitant CCA lesions were treated by distal CCA transection and proximal eversion endarterectomy (>3 cm length) in 19 cases, retrograde proximal CCA or innominate stenting in 7, and polytetrafluoroethylene bypass replacement in 3 patients. The 30-day adverse events and late reconstruction patency were compared with 3 concurrent patient control groups including 185 standard CEAs for isolated bifurcation disease, 21 transfemoral carotid artery stenting procedures for high-risk indications, and 31 primary stenting procedures of arch origin stenoses (CCA or innominate). Simultaneous CEA with open cardiac surgery and cross CCA-CCA bypass cases were excluded; 85% of patients had follow-up imaging beyond 30 to 60 days with an annual surveillance duplex ultrasound (mean duration of 2.7 years; range to 9 years).
Results: No statistically significant differences were found in early adverse event rates and late recurrent high-grade stenosis between the complex/hybrid carotid repair group and any of the control cohorts (Table) . No stroke or early deaths occurred after the more complex repairs, and neck wound and hematoma complications were few. Late restenosis was seen more frequently within arch origin stents than at the reconstructed carotid bifurcation.
Conclusions: An aggressive approach using complex/hybrid carotid repair techniques is supported by these results and can be offered without increased risk to patients with multisite or recurrent CVOD. Methods: The American College of Surgeons National Surgical Quality Improvement Program database was queried among all participating institutions for CEAs performed in 2011 to 2015. Patients' demographic data, comorbid conditions, preprocedure medication use, and operative variables were analyzed using multivariate logistic regression analysis to determine predictors of postoperative MACEs.
Results: There were 17,888 patients who underwent CEA analyzed; the patients were grouped by age (<75 and $75 years old) and whether they presented symptomatically (SYM) or asymptomatically (AS) before the procedure. For AS patients <75 years, the rate of stroke, myocardial infarction (MI), death, and MACEs was 1.8%, 1.6%, 0.4%, and 3.6%, respectively; for patients $75 years, rates were 1.7%, 2.3%, 0.7%, and 4.3%. The rate of MI was significantly higher in older patients (P ¼ .0133). The odds of postoperative stroke was 73% higher (P < .0011) in diabetics, 57% higher (P ¼ .0109) with American Society of Anesthesiologists (ASA) score 4 or 5, and 34% higher with operative time >2.5 hours (P ¼ .0189). SYM patients $75 years had 1.1 times higher risk of postoperative stroke if they had insulin-dependent diabetes (P ¼ .0148). Reintubation and reoperation were associated with increased risk of postoperative stroke in both age groups, whether SYM or AS (P < .0001), as well as postoperative MI (P < .0001). AS patients <75 years had higher likelihood of postoperative MI if they had history of congestive heart failure (P ¼ .0257) and operative time >2.5 hours (P ¼ .0033). SYM patients $75 years had 46% higher likelihood of postoperative MI if operative time >2.5 hours (P ¼ .0023). Mortality was higher in AS patients <75 years with ASA score 4 or 5 (P ¼ .0006) and those $75 years (P ¼ .0072) and in patients who were reintubated (P < .0001). In SYM patients <75 years, the rate of stroke, MI, death, and MACEs was 4.8%, 1.4%, 0.9%, and 6.3%, respectively. In those $75 years, rates were 4.9%, 2.6%, 1.6%, and 7.8%. Older patients had higher rates of MI and MACEs (P ¼ .001 and P¼ .0103). SYM patients <75 years had higher mortality if they had chronic obstructive pulmonary disease (P ¼ .0002) and diabetes (P ¼ .0062). SYM patients of all ages had higher mortality with postoperative stroke or MI (P < 0.0001).
Conclusions: Patients 75 years or older are at increased risk of postoperative MI after CEA regardless of symptomatic status. Diabetes, increased operative time, and ASA score 4 or 5 were associated with higher MACE rates among all age groups.
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Heterotopic Objective: Heterotopic ossification (HO) can be defined as pathologic ectopic bone growth in soft tissue. Most reported instances of HO occur after trauma and operations involving bones and joints, such as wartime injuries (high-energy blast injuries), traumatic brain injuries, traumatic and combatrelated amputations, arthroplasties, and total joint replacements. HO has also been reported in patients with significant neurologic deficits, such as stroke, quadriplegia, and other injuries leading to long-term immobilization.
Methods: This report describes the case of a 61-year-old man with a complicated medical and surgical history who presented to our clinic with pain in his stump 8 weeks after an above-knee amputation. This amputation level was chosen to revise a previous below-knee amputation because of osteomyelitis of the distal fibula. Workup of his lingering discomfort included repeated lower extremity radiographs (Figs 1 and 2) . These studies showed signs of HO at the distal portion of the amputated femur. The patient was taken to the operating room for his above-knee amputation. Intraoperatively, he was found to have HO of the distal femur, which was revised to a higher level. The patient had an uneventful postoperative course with resolution of his pain.
Results: Studies regarding HO occurrence after lower extremity amputation are most robust in combat-related and traumatic amputations. In addition, HO has been well studied in pediatric populations. One retrospective study and a few case reports describe HO after atraumatic amputations in adult civilians, and the incidence was similar compared with traumatic amputations. Postamputation pain is a common occurrence in patients who undergo amputation, leading to a significant burden on the health care system, particularly in the Veterans Affairs system. Current literature suggests that HO may be an under-reported mechanism by which patients have postsurgical stump pain, even in atraumatic amputations. Surgical excision has been shown to be highly effective in managing postamputation pain associated with HO.
Conclusions: This case report adds to the growing evidence that HO should be considered in the differential diagnosis for any patient with postamputation pain and should be confirmed with radiographic examination of the stump.
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IP131. Preoperative Indicators for Venous Complications Associated With Implanted Ports
Madeline Heald, Robert Netzley, Dennis Wright, Loren Masterson, Jill Zink. Cleveland Clinic Akron General, Akron, Ohio
Objective: Central venous ports have been a critical part of prolonged venous access for a variety of different indications, including chemotherapy, nutritional support, repeated administration of blood products, and frequent blood draws. Complications of these ports cause delays in treatment, increased morbidity, and increased medical expenses. The ability to identify patients at risk for complications can allow prevention and alternative therapies, resulting in improved outcomes, patient care, and satisfaction. The aim of this study was to identify preoperative indicators associated with complications from implanted central venous ports.
Methods: A retrospective review of 1105 charts was performed during 15 years (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) . Evaluation of placement site, indication for procedure, and diagnostic laboratory values were reviewed to determine their significance related to port complications.
Results: A total of 1105 ports were placed (938 arm and 165 chest). The overall complication rate (ie, infection, thrombosis, erosion, and mechanical failure) was 12.3%, with 94 patients (8.5%) developing an infection and 29 patients (2.6%) developing deep venous thrombosis or thrombosis. There was no significant difference in overall complication rate with respect to the implantation site (P ¼ .442). Of the ports placed, 294 had a preprocedure white blood cell (WBC) count within 5 days of port placement; 40 patients had a WBC count of 4.4 Â 10 3 cells/mL and 88 had a WBC count of 9.7 Â 10 3 cells/mL. A WBC count outside the normal range (4.4 Â 10 3 or 9.7 Â 10 3 cells/mL) had a significantly higher complication rate (P ¼ .024). Ports placed for a nonmalignant indication (eg, anemia, depression) were associated with an increased complication rate (P < .001). Ports placed for breast malignant neoplasms had a lower risk of port complication.
Conclusions:
We have identified multiple factors that appear to increase the risk for development of a complication from an implanted central venous port. WBC count appears to have a significant association with complication rates after implantation. Both infection and thrombosis rates were increased with WBC count outside the normal limit. If possible, one should consider delaying port placement until the WBC count normalizes, using alternative venous access to decrease serious complications. Ports placed for a nonmalignant indication had a significantly increased complication rate. Further evaluation is needed to determine whether alternative access will improve outcomes in this group of patients.
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Type III Endoleaks Are Not Significantly Increasing Over Time 
